首页> 外文期刊>Dermatology: international journal for clinical and investigative dermatology >Photosensitivity with sulfasalazopyridine hypersensitivity syndrome.
【24h】

Photosensitivity with sulfasalazopyridine hypersensitivity syndrome.

机译:光敏性与柳氮磺吡啶吡啶超敏综合征。

获取原文
获取原文并翻译 | 示例
           

摘要

Five weeks after the start of treatment with an association of sulfasalazopyridine and piroxicam, a 30-year-old woman presented with an eczematous eruption in light-exposed areas, hepatomegaly and fever (38 degrees C). Laboratory studies showed leukocytosis, eosinophilia and hepatic cytolysis. Treatment consisted of withdrawing the two drugs and topical steroids. The clinical signs regressed in 6 days. An increase in eosinophilia and hepatic cytolysis was observed until the tenth day, after which the trend reversed. Laboratory parameters were normal on the twentieth day. One month later, photopatch testing was performed. A patch test with sulfanilamide irradiated with UVA was positive. Clinical and laboratory findings were highly suggestive of drug hypersensitivity syndrome. The positive result from the UVA photopatch test with sulfanilamide suggests that sulfasalazopyridine was involved in the occurrence of hypersensitivity syndrome in our patient. We conclude that photodistributed eruptions can be observed in drug hypersensitivity syndrome with photosensitizing drugs.
机译:在开始使用磺胺嘧啶并吡啶和吡罗昔康联合治疗的五周后,一名30岁妇女在光照,肝肿大和发烧(38摄氏度)时出现了湿疹性湿疹。实验室研究显示白细胞增多,嗜酸性粒细胞增多和肝细胞溶解。治疗包括撤回两种药物和局部类固醇。临床症状在6天内消退。观察到嗜酸性粒细胞增多和肝细胞溶解增加,直到第十天,之后趋势逆转。第二十天的实验室参数正常。一个月后,进行了光补丁测试。 UVA照射的磺胺的斑贴试验为阳性。临床和实验室检查结果高度提示药物过敏综合征。磺胺类药物的UVA光斑试验的阳性结果表明,磺胺嘧啶并吡啶与我们患者的超敏反应综合征有关。我们得出的结论是,在具有光敏药物的药物超敏综合征中可以观察到光分布的爆发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号